High amplification levels of MDM2 and CDK4 correlate with poor outcome in patients with dedifferentiated liposarcoma: a cytogenomic microarray analysis of 47 cases

Regulation of p53 stability by Mdm2

Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312 · see citing works

Absolute quantification by droplet digital PCR versus analog real-time PCR

Hindson, C. M., Chevillet, J. R., Briggs, H. A., Gallichotte, E. N., Ruf, I. K., Hindson, B. J., Vessella, R. L., & Tewari, M. (2013) · Nature Methods · doi:10.1038/nmeth.2633 · Cited by 1,488 · see citing works

Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4

(1993) · Genes & Development · doi:10.1101/gad.7.3.331 · Cited by 1,264 · see citing works

Chromosome aberrations in solid tumors

Albertson, D. G., Collins, C., McCormick, F., & Gray, J. W. (2003) · Nature Genetics · doi:10.1038/ng1215 · Cited by 812 · see citing works

Dedifferentiated Liposarcoma

Henricks, W. H., Chu, Y. C., Goldblum, J. R., & Weiss, S. W. (1997) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199703000-00002 · Cited by 634 · see citing works

Subtype Specific Prognostic Nomogram for Patients With Primary Liposarcoma of the Retroperitoneum, Extremity, or Trunk

Dalal, K. M., Kattan, M. W., Antonescu, C. R., Brennan, M. F., & Singer, S. (2006) · Annals of Surgery · doi:10.1097/01.sla.0000234795.98607.00 · Cited by 421 · see citing works

Sonic hedgehog increases the commitment of pluripotent mesenchymal cells into the osteoblastic lineage and abolishes adipocytic differentiation

Spinella-Jaegle, S., Rawadi, G., Kawai, S., Gallea, S., Faucheu, C., Mollat, P., Courtois, B., Bergaud, B., Ramez, V., Blanchet, A., et al. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.11.2085 · Cited by 267 · see citing works

JUN Oncogene Amplification and Overexpression Block Adipocytic Differentiation in Highly Aggressive Sarcomas

Mariani, O., Louis‐Brennetot, C., Coindre, J., Gruel, N., Ganem‐Elbaz, C., Delattre, O., Stern, M., & Aurias, A. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.02.007 · Cited by 210 · see citing works

HMGA2 is the partner of MDM2 in well‐differentiated and dedifferentiated liposarcomas whereas CDK4 belongs to a distinct inconsistent amplicon

Italiano, A., Bianchini, L., Keslair, F., Bonnafous, S., Cardot‐Leccia, N., Coindre, J., Dumollard, J., Hofman, P. M., Leroux, A., Mainguene, C., et al. (2008) · International Journal of Cancer · doi:10.1002/ijc.23380 · Cited by 208 · see citing works

Potent and orally active small-molecule inhibitors of the MDM2-p53 interaction

Yu, S., Qin, D., Shangary, S., Chen, J., Wang, G., Ding, K., McEachern, D., Qiu, S., Nikolovska-Coleska, Z., Miller, R., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm901400z · Cited by 180 · see citing works

DISTINCT mdm2/p53 EXPRESSION PATTERNS IN LIPOSARCOMA SUBGROUPS: IMPLICATIONS FOR DIFFERENT PATHOGENETIC MECHANISMS

Pilotti, S., Torre, G. D., Lavarino, C. E., Palma, S. D., Sozzi, G., Minoletti, F., Rao, S., PASQUINI, G., Azzarelli, A., Rilke, F. O., et al. (1997) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199701)181:1 · Cited by 149 · see citing works

Clinical and Biological Significance of CDK4 Amplification in Well-Differentiated and Dedifferentiated Liposarcomas

Italiano, A., Bianchini, L., Gjernes, E., Keslair, F., Ranchère‐Vince, D., Dumollard, J., Haudebourg, J., Leroux, A., Mainguene, C., Terrier, P., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-3185 · Cited by 141 · see citing works

Hedgehog signaling overrides p53-mediated tumor suppression by activating Mdm2

Abe, Y., Oda-Sato, E., Tobiume, K., Kawauchi, K., Taya, Y., Okamoto, K., Oren, M., & Tanaka, N. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712216105 · Cited by 135 · see citing works

Antiproliferative Effects of CDK4/6 Inhibition in <i>CDK4</i> -Amplified Human Liposarcoma <i>In Vitro</i> and <i>In Vivo</i>

Zhang, Y.-X., Sicinska, E., Czaplinski, J. T., Remillard, S. P., Moss, S., Wang, Y., Brain, C., Loo, A., Snyder, E. L., Demetri, G. D., et al. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-0387 · Cited by 114 · see citing works

Amplification of FRS2 and Activation of FGFR/FRS2 Signaling Pathway in High-Grade Liposarcoma

Zhang, K., Chu, K., Wu, X., Gao, H., Wang, J., Yuan, Y., Loera, S., Ho, K., Wang, Y., Chow, W. A., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2086 · Cited by 98 · see citing works

The Myxoid/Round Cell Liposarcoma Fusion Oncogene FUS-DDIT3 and the Normal DDIT3 Induce a Liposarcoma Phenotype in Transfected Human Fibrosarcoma Cells

Engström, K., Willén, H., Gustafsson, C. K., Andersson, C., Olsson, M., Göransson, M., Järnum, S., Olofsson, A., Warnhammar, E., & Åman, P. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.050872 · Cited by 98 · see citing works

Evaluation of well‐differentiated/de‐differentiated liposarcomas by high‐resolution oligonucleotide array‐based comparative genomic hybridization

Tap, W. D., Eilber, F. C., Ginther, C., Dry, S., Reese, N., Smith, K. B., Chen, H., Wu, H., Eilber, F. R., Slamon, D. J., et al. (2010) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20835 · Cited by 98 · see citing works

Prognostic value of HMGA2, CDK4, and JUN amplification in well-differentiated and dedifferentiated liposarcomas

Saâda-Bouzid, E., Burel‐Vandenbos, F., Ranchère‐Vince, D., Birtwisle‐Peyrottes, I., Chetaille, B., Bouvier, C., Chateau, M., Péoc’h, M., Battistella, M., Bazin, A., et al. (2015) · Modern Pathology · doi:10.1038/modpathol.2015.96 · Cited by 95 · see citing works

c‐Jun amplification and overexpression are oncogenic in liposarcoma but not always sufficient to inhibit the adipocytic differentiation programme

Snyder, E. L., Sandstrom, D. J., Law, K., Fiore, C., Sicińska, E., Brito, J. M., Bailey, D., Fletcher, J. A., Loda, M. F., Rodig, S. J., et al. (2009) · The Journal of Pathology · doi:10.1002/path.2564 · Cited by 89 · see citing works

GAS41 Is Required for Repression of the p53 Tumor Suppressor Pathway during Normal Cellular Proliferation

Park, J. H., & Roeder, R. G. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.02185-05 · Cited by 86 · see citing works

BMP-2 and Sonic Hedgehog Have Contrary Effects on Adipocyte-Like Differentiation of C3H10T1/2 Cells

Zehentner, B. K., Leser, U., & BURTSCHER, H. J. (2000) · DNA and Cell Biology · doi:10.1089/10445490050021186 · Cited by 84 · see citing works

Copy Number Losses Define Subgroups of Dedifferentiated Liposarcoma with Poor Prognosis and Genomic Instability

Crago, A. M., Socci, N. D., DeCarolis, P. L., O’Connor, R., Taylor, B. S., Qin, L., Antonescu, C. R., & Singer, S. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2820 · Cited by 76 · see citing works

MDM2 Copy Numbers in Well-Differentiated and Dedifferentiated Liposarcoma

Ware, P. L., Snow, A. N., Gvalani, M., Pettenati, M. J., & Qasem, S. A. (2014) · American Journal of Clinical Pathology · doi:10.1309/ajcplyu89xhsnhqo · Cited by 71 · see citing works

Similarity in genetic alterations between paired well-differentiated and dedifferentiated components of dedifferentiated liposarcoma

Horvai, A., DeVries, S., Roy, R., O’Donnell, R. J., & Waldman, F. M. (2009) · Modern Pathology · doi:10.1038/modpathol.2009.119 · Cited by 68 · see citing works

ASK1 ( MAP3K5 ) as a potential therapeutic target in malignant fibrous histiocytomas with 12q14–q15 and 6q23 amplifications

Chibon, F., Mariani, O., Derré, J., Mairal, A., Coindre, J., Guillou, L., Sastre‐Garau, X., Pédeutour, F., & Aurias, A. (2004) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20012 · Cited by 66 · see citing works

High‐resolution genomic mapping reveals consistent amplification of the fibroblast growth factor receptor substrate 2 gene in well‐differentiated and dedifferentiated liposarcoma

Wang, X., Asmann, Y. W., Erickson‐Johnson, M. R., Oliveira, J. L., Zhang, H., Moura, R. D. D., Lazar, A. J., Lev, D. C., Bill, K., Lloyd, R. V., et al. (2011) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20906 · Cited by 57 · see citing works

High level of CDK4 amplification is a poor prognostic factor in well-differentiated and dedifferentiated liposarcoma.

Lee, S. E., Kim, Y. J., Kwon, M. J., Choi, D. I., Lee, J., Cho, J., Seo, S. W., Kim, S. J., Shin, Y. K., & Choi, Y. (2014) · PubMed · doi:10.14670/hh-29.127 · Cited by 55 · see citing works

Characterization of the 12q amplicons by high-resolution, oligonucleotide array CGH and expression analyses of a novel liposarcoma cell line

Persson, F., Olofsson, A., Sjögren, H., Chebbo, N., Nilsson, B., Stenman, G., & Åman, P. (2007) · Cancer Letters · doi:10.1016/j.canlet.2007.10.032 · Cited by 53 · see citing works

Prognostic relevance of Fédération Nationale des Centres de Lutte Contre le Cancer grade and MDM2 amplification levels in dedifferentiated liposarcoma: a study of 50 cases

Jour, G., Gullett, A. E., Liu, M., & Hoch, B. L. (2014) · Modern Pathology · doi:10.1038/modpathol.2014.88 · Cited by 49 · see citing works

Absence or low number of telomere repeats at junctions of dicentric chromosomes

Wan, T. S. K., Martens, U. M., Poon, S. S. S., Tsao, S., Ha, S., & Lansdorp, P. M. (1999) · Genes Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199901)24:1 · Cited by 45 · see citing works

Characterization of the 12q amplicons in lipomatous soft tissue tumors by multiplex ligation-dependent probe amplification-based copy number analysis.

Creytens, D., van Gorp, J., Speel, E. M., & Ferdinande, L. (2015) · PubMed · Cited by 43 · see citing works

Use of droplet digital PCR for quantitative and automatic analysis of the HER2 status in breast cancer patients

Otsuji, K., Sasaki, T., Tanaka, A., Kunita, A., Ikemura, M., Matsusaka, K., Tada, K., Fukayama, M., & Seto, Y. (2016) · Breast Cancer Research and Treatment · doi:10.1007/s10549-016-4092-5 · Cited by 31 · see citing works

CDK4 Amplification Predicts Recurrence of Well-Differentiated Liposarcoma of the Abdomen

Lee, S., Park, H., Ha, S. Y., Paik, K. Y., Lee, S. E., Kim, J. M., Park, J. B., Kwon, C. H. D., Joh, J., Choi, Y., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099452 · Cited by 25 · see citing works

In vitro and in silico studies of MDM2/MDMX isoforms predict Nutlin-3A sensitivity in well/de-differentiated liposarcomas

Bozzi, F., Conca, E., Laurini, E., Posocco, P., Sardo, A. L., Jocollé, G., Sanfilippo, R. G., Gronchi, A., Perrone, F., Tamborini, E., et al. (2013) · Laboratory Investigation · doi:10.1038/labinvest.2013.107 · Cited by 20 · see citing works

Detection of Clonal Evolution in Hematopoietic Malignancies by Combining Comparative Genomic Hybridization and Single Nucleotide Polymorphism Arrays

Hartmann, L., Stephenson, C. F., Verkamp, S., Johnson, K. R., Burnworth, B., Hammock, K., Brodersen, L. E., de Baca, M. E., Wells, D. A., Loken, M. R., et al. (2014) · Clinical Chemistry · doi:10.1373/clinchem.2014.227785 · Cited by 19 · see citing works

Recurrent genetic alterations in hepatitis C-associated hepatocellular carcinoma detected by genomic microarray: a genetic, clinical and pathological correlation study

Liu, Y. J., Zhou, Y., & Yeh, M. M. (2014) · Molecular Cytogenetics · doi:10.1186/s13039-014-0081-8 · Cited by 18 · see citing works

Quantitative DNA Analysis Using Droplet Digital PCR

Vossen, R. H. A. M., & White, S. J. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-6442-0_11 · Cited by 17 · see citing works

Translocated in liposarcoma (TLS) is a substrate for fibroblast growth factor receptor-1

Klint, P., Hellman, U., Wernstedt, C., Åman, P., Ron, D., & Claesson, L. (2003) · Cellular Signalling · doi:10.1016/j.cellsig.2003.09.007 · Cited by 11 · see citing works

MDM2 Amplified Sarcomas: A Literature Review

Sciot, R. (2021) · Diagnostics · doi:10.3390/diagnostics11030496 · Cited by 96 · see citing works

Dedifferentiated Liposarcoma: Systemic Therapy Options

Gahvari, Z. J., & Parkes, A. M. (2020) · Current Treatment Options in Oncology · doi:10.1007/s11864-020-0705-7 · Cited by 90 · see citing works

Biology and Management of Dedifferentiated Liposarcoma: State of the Art and Perspectives

Nishio, J., Nakayama, S., Nabeshima, K., & Yamamoto, T. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10153230 · Cited by 84 · see citing works

Rational drug design, synthesis, and biological evaluation of novel chiral tetrahydronaphthalene-fused spirooxindole as MDM2-CDK4 dual inhibitor against glioblastoma

Wang, B., Peng, F., Huang, W., Zhou, J., Zhang, N., Sheng, J., Haruehanroengra, P., He, G., & Han, B. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2019.12.013 · Cited by 73 · see citing works

A review of retroperitoneal liposarcoma genomics

Tyler, R., Wanigasooriya, K., Tanière, P., Almond, M., Ford, S., Desai, A., & Beggs, A. D. (2020) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2020.102013 · Cited by 68 · see citing works

Targeting the MDM2-p53 pathway in dedifferentiated liposarcoma

Traweek, R. S., Cope, B. M., Roland, C. L., Keung, E. Z.-Y., Nassif, E. F., & Erstad, D. J. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1006959 · Cited by 61 · see citing works

Copy number amplification and SP1-activated lncRNA MELTF-AS1 regulates tumorigenesis by driving phase separation of YBX1 to activate ANXA8 in non-small cell lung cancer

Lu, X., Wang, J., Wang, W. T., Lu, C., Qu, T., He, X., Liu, X., Guo, R., & Zhang, E. (2022) · Oncogene · doi:10.1038/s41388-022-02292-z · Cited by 59 · see citing works

MDM2-p53 in liposarcoma: The need for targeted therapies with novel mechanisms of action

Somaiah, N., & Tap, W. D. (2023) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2023.102668 · Cited by 45 · see citing works

Selinexor in Advanced, Metastatic Dedifferentiated Liposarcoma: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial

Gounder, M. M., Razak, A. A., Somaiah, N., Chawla, S. P., Martín‐Broto, J., Grignani, G., Schuetze, S. M., Vincenzi, B., Wagner, A. J., Chmielowski, B., et al. (2022) · Journal of Clinical Oncology · doi:10.1200/jco.21.01829 · Cited by 45 · see citing works

Amplification of DNA damage-inducible transcript 3 (DDIT3) is associated with myxoid liposarcoma-like morphology and homologous lipoblastic differentiation in dedifferentiated liposarcoma

Mantilla, J. G., Ricciotti, R. W., Chen, E. Y., Liu, Y. J., & Hoch, B. L. (2018) · Modern Pathology · doi:10.1038/s41379-018-0171-y · Cited by 44 · see citing works

Degree of MDM2 Amplification Affects Clinical Outcomes in Dedifferentiated Liposarcoma

Bill, K. L. J., Seligson, N. D., Hays, J. L., Awasthi, A., Demoret, B., Stets, C. W., Duggan, M. C., Bupathi, M., Brock, G. N., Millis, S. Z., et al. (2019) · The Oncologist · doi:10.1634/theoncologist.2019-0047 · Cited by 42 · see citing works

CD4+ T cell and M2 macrophage infiltration predict dedifferentiated liposarcoma patient outcomes

Schroeder, B., LaFranzo, N. A., LaFleur, B., Gittelman, R., Vignali, M., Zhang, S., Flanagan, K. C., Rytlewski, J. A., Riolobos, L., Schulte, B. C., et al. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-002812 · Cited by 42 · see citing works

Molecular updates in adipocytic neoplasms✰

Demicco, E. G. (2019) · Seminars in Diagnostic Pathology · doi:10.1053/j.semdp.2019.02.003 · Cited by 32 · see citing works

Treatment of De-Differentiated Liposarcoma in the Era of Immunotherapy

Zhou, M. Y., Bui, N. Q., Charville, G. W., Ganjoo, K. N., & Pan, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119571 · Cited by 28 · see citing works

Update on genomic and molecular landscapes of well-differentiated liposarcoma and dedifferentiated liposarcoma

Lu, J., Wood, D., Ingley, E., Kõks, S., & Wong, D. (2021) · Molecular Biology Reports · doi:10.1007/s11033-021-06362-5 · Cited by 26 · see citing works

Amplification of CDK4 and MDM2: a detailed study of a high-risk neuroblastoma subgroup

Martinez‐Monleon, A., Kryh, H., Gaarder, J., Berbegall, A. P., Javanmardi, N., Djos, A., Ussowicz, M., Taschner‐Mandl, S., Ambros, I. M., Øra, I., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-16455-1 · Cited by 23 · see citing works

Inhibition of histone deacetylase 2 reduces MDM2 expression and reduces tumor growth in dedifferentiated liposarcoma

Seligson, N. D., Stets, C. W., Demoret, B., Awasthi, A., Grosenbacher, N., Shakya, R., Hays, J. L., & Chen, J. L. (2019) · Oncotarget · doi:10.18632/oncotarget.27144 · Cited by 20 · see citing works

Targeted Inhibition of the PI3K/Akt/mTOR Signaling Axis: Potential for Sarcoma Therapy

Wani, A. K., Singh, R., Akhtar, N., Prakash, A., Nepovimová, E., Olekšák, P., Chrienová, Ž., Alomar, S. Y., Chopra, C., & Kuča, K. (2024) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/0113895575270904231129062137 · Cited by 19 · see citing works

Double amplifications of CDK4 and MDM2 in a gastric inflammatory myofibroblastic tumor mimicking cancer with local invasion of the spleen and diaphragm

He, J., Zhao, X., Huang, C., Zhou, X., You, Y., Zhang, L., Lu, C., Yao, F., & Li, S. (2018) · Cancer Biology &amp; Therapy · doi:10.1080/15384047.2018.1480290 · Cited by 17 · see citing works

Prognostic significance of the MDM2 / HMGA2 ratio and histological tumor grade in dedifferentiated liposarcoma

Yamashita, K., Kohashi, K., Yamada, Y., Akatsuka, S., Ikuta, K., Nishida, Y., Toyokuni, S., & Oda, Y. (2020) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22899 · Cited by 17 · see citing works

MDM2-Dependent Rewiring of Metabolomic and Lipidomic Profiles in Dedifferentiated Liposarcoma Models

Patt, A. C., Demoret, B., Stets, C. W., Bill, K. L. J., Smith, P. B. W., Vijay, A., Patterson, A. D., Hays, J. L., Hoang, M., Chen, J. L., et al. (2020) · Cancers · doi:10.3390/cancers12082157 · Cited by 16 · see citing works

Spindle cell liposarcoma with a TRIO-TERT fusion transcript

Suster, D. I., Deshpande, V., Chebib, I. A., Taylor, M. S., Mullen, J. T., Bredella, M. A., & Nielsen, G. P. (2019) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-019-02545-5 · Cited by 16 · see citing works

The clinical significance of perioperative inflammatory index as a prognostic factor for patients with retroperitoneal soft tissue sarcoma

Matsui, Y., Matsuda, A., Maejima, A., Shinoda, Y., Nakamura, E., Komiyama, M., & Fujimoto, H. (2022) · International Journal of Clinical Oncology · doi:10.1007/s10147-022-02150-8 · Cited by 16 · see citing works

An absolute approach to using whole exome DNA and RNA workflow for cancer biomarker testing

Malhotra, R., Javle, V., Tanwar, N., Gowda, P., Varghese, L., Anju, K., Madhusudhan, N., Jaiswal, N., Bhargavi, K. S., Chatterjee, M., et al. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1002792 · Cited by 15 · see citing works

Gene amplification and tumor grading in parosteal osteosarcoma

Chen, P. C.-H., Yen, C., Hung, G., Pan, C., & Chen, W. (2019) · Journal of the Chinese Medical Association · doi:10.1097/jcma.0000000000000211 · Cited by 15 · see citing works

Palbociclib in Solid Tumor Patients With Genomic Alterations in the cyclinD-cdk4/6-INK4a-Rb Pathway: Results From National Cancer Institute-Children's Oncology Group Pediatric Molecular Analysis for Therapy Choice Trial Arm I (APEC1621I)

Macy, M. E., Mody, R. J., Reid, J. M., Piao, J., Saguilig, L., Alonzo, T. A., Berg, S. L., Fox, E., Weigel, B. J., Hawkins, D. S., et al. (2024) · JCO Precision Oncology · doi:10.1200/po-24-00418 · Cited by 12 · see citing works

Soft Tissue Sarcomas with Chromosomal Alterations in the 12q13-15 Region: Differential Diagnosis and Therapeutic Implications

Lavernia, J., Claramunt, R., Romero, I., López‐Guerrero, J. A., Llombart-Bosch, A., & Machado, I. (2024) · Cancers · doi:10.3390/cancers16020432 · Cited by 10 · see citing works

Extracellular Vesicle—MDM2-DNA as a Potential Liquid Biopsy Biomarker for Disease Identification in Retroperitoneal Liposarcoma

Calore, F., Casadei, L., Sarchet, P., Fadda, P., Nigita, G., Coombes, K. R., Cascione, L., de Faria, F. C. C., Tahara, S., Iwenofu, O. H., et al. (2024) · Annals of Surgery · doi:10.1097/sla.0000000000006345 · Cited by 10 · see citing works

The utility of fluorescence in situ hybridization (FISH) in determining DNA damage-inducible transcript 3 (DDIT3) amplification in dedifferentiated liposarcomas – an important diagnostic pitfall

Kuczkiewicz‐Siemion, O., Wiśniewski, P., Dansonka‐Mieszkowska, A., Grabowska-Kierył, M., Olszewska, K., Goryń, T., Prochorec‐Sobieszek, M., Rutkowski, P. L., & Szumera‐Ciećkiewicz, A. (2021) · Pathology - Research and Practice · doi:10.1016/j.prp.2021.153555 · Cited by 10 · see citing works

CDK4 Amplification in Esophageal Squamous Cell Carcinoma Associated With Better Patient Outcome

Huang, J., Wang, X., Zhang, X., Chen, W., Luan, L., Song, Q., Wang, H., Liu, J., Xu, L., Xu, Y., et al. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.616110 · Cited by 10 · see citing works

Phase II Study of Palbociclib in Patients with Tumors with CDK4 or CDK6 Amplification: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol Z1C

O’Hara, M. H., Jegede, O. A., Dickson, M. A., DeMichele, A. M., Piekarz, R., Gray, R. J., Wang, V., McShane, L. M., Rubinstein, L., Patton, D. R., et al. (2024) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-24-0036 · Cited by 9 · see citing works

The combination of gemcitabine and docetaxel arrests a doxorubicin-resistant dedifferentiated liposarcoma in a patient-derived orthotopic xenograft model

Miyake, K., Higuchi, T., Oshiro, H., Zhang, Z., Sugisawa, N., Park, J. H., Razmjooei, S., Katsuya, Y., Barangi, M., Li, Y., et al. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109093 · Cited by 9 · see citing works

Primary cardiac sarcomas: A clinicopathologic study in a single institution with 25 years of experience with an emphasis on MDM2 expression and adjuvant therapy for prognosis

Cho, H., Song, I. H., Jo, U., Jeong, J., Koo, H. J., Yang, D. H., Jung, S., Song, J. S., & Cho, K. (2023) · Cancer Medicine · doi:10.1002/cam4.6303 · Cited by 9 · see citing works

An update on mesenchymal tumours of the orbit with an emphasis on the value of molecular/cytogenetic testing

Roberts, F., & MacDuff, E. (2018) · Saudi Journal of Ophthalmology · doi:10.1016/j.sjopt.2018.02.010 · Cited by 9 · see citing works

Prognostic Implications of MDM2 and CDK4 Co-amplification in Liposarcoma: Insights from FISH analysis for Translational Oncology

James, J., Yajid, A. I., Yahaya, S., Abdullah, S., & Sharif, S. E. T. (2025) · Clinical & Translational Oncology · doi:10.1007/s12094-025-03989-9 · Cited by 9 · see citing works

MicroRNA ‐215‐5p promotes proliferation, invasion, and inhibits apoptosis in liposarcoma cells by targeting MDM2

Song, Z., Bai, J., Jiang, R., Wu, J., & Yang, W. (2023) · Cancer Medicine · doi:10.1002/cam4.5993 · Cited by 8 · see citing works

Next generation sequencing in a cohort of patients with rare sarcoma histotypes: A single institution experience

Tirrò, E., Martorana, F., Micale, G., Inzerilli, N., Carciotto, R., Romano, C., Longhitano, C., Motta, G., Lanzafame, K., Stella, S., et al. (2022) · Pathology - Research and Practice · doi:10.1016/j.prp.2022.153820 · Cited by 7 · see citing works

Next-generation sequencing-based genomic profiling of advanced soft tissue and bone sarcomas

Gündoğdu, Y., Taşçı, E. Ş., Özer, L., Boynukara, C., Çeçen, R., Mutlu, A. U., & Yıldız, İ. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1627452 · Cited by 6 · see citing works

Deceptive Giant Dedifferentiated Liposarcoma of the Esophagus: An Extremely Rare Surgical Case

Shi, X.-X., Liao, M., Tao, L., Wang, X., & Yin, W.-H. (2019) · International Journal of Surgical Pathology · doi:10.1177/1066896919873078 · Cited by 4 · see citing works

Real-world survival outcomes and MDM2 prevalence in US patients with metastatic dedifferentiated liposarcoma

Robinson, S. I., Klein, A., Stanhope, S. A., Evans, K., & Agulnik, M. (2025) · Future Oncology · doi:10.1080/14796694.2025.2502319 · Cited by 3 · see citing works

Clinicopathological and genomic profiling in undifferentiated pleomorphic sarcoma: Small series, clear message

Remiszewski, P., Tysarowski, A., Seliga, K. A., Bobak, K., Piątkowski, J., Golik, P., Spalek, M. J., Szumera‐Ciećkiewicz, A., Wągrodzki, M., Rutkowski, P. L., et al. (2025) · Journal of Applied Genetics · doi:10.1007/s13353-025-01036-5 · Cited by 3 · see citing works

Primary dedifferentiated liposarcoma of the gallbladder: a case report and literature review

Wang, L., Lin, T., Hai, Y., Yu, K., Bu, F., Lu, J., Wang, X., Li, M., & Shi, X. (2024) · Frontiers in Surgery · doi:10.3389/fsurg.2024.1452144 · Cited by 3 · see citing works

A century of retroperitoneal soft-tissue sarcoma research: From single center experience to precision oncology? A bibliometric analysis of past, present, and future perspectives

Musa, J., Willis, F. M., Harnoss, J. M., Rompen, I. F., Sauerteig, C., Kochendoerfer, S. M., Grünewald, T. G. P., Al‐Saeedi, M., Schneider, M., & Harnoss, J.-C. (2023) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2023.05.023 · Cited by 3 · see citing works

Obvious Reduction of the Tumor Size in Dedifferentiated Liposarcoma in a Lung Metastasis Patient Receiving Individualized Treatment

Wang, X., Gong, J.-Y., & Xue, Y. (2021) · Case Reports in Oncology · doi:10.1159/000512519 · Cited by 3 · see citing works

Delayed use of Eribulin in a Heavily Pretreated Liposarcoma Patient, Previously Misdiagnosed as Leiomyosarcoma

Martorana, F., Vigneri, P. G., Manzella, L., Tirrò, E., & Parra, H. J. S. (2020) · Future Oncology · doi:10.2217/fon-2019-0596 · Cited by 3 · see citing works

Radiation therapy and molecular‐targeted agents in preclinical testing for immunotherapy, brain tumors, and sarcomas: Opportunities and challenges

Vatner, R. E., James, C. D., Sathiaseelan, V., Bondra, K. M., Kalapurakal, J. A., & Houghton, P. J. (2020) · Pediatric Blood & Cancer · doi:10.1002/pbc.28439 · Cited by 3 · see citing works

Predictors of survival in dedifferentiated liposarcoma: A population-based analysis of the SEER database

Obeidat, A. S. (2026) · Medicine · doi:10.1097/md.0000000000047738 · Cited by 2 · see citing works

Vanished MDM2 amplification in multiple recurrences of an irradiated poorly differentiated sarcoma with amplified TRIO::TERT fusion gene

Goffinet, S., Mauro, I. D., Doyen, J., Boyer, J., Birtwisle‐Peyrottes, I., Keslair, F., Pédeutour, F., & Dadone‐Montaudié, B. (2023) · Genes Chromosomes and Cancer · doi:10.1002/gcc.23137 · Cited by 2 · see citing works

The role of histology, grading, location of tumour and ploidy in evaluation of outcome in patients with liposarcoma

Harazin-Lechowska, A., Lackowska, B., Ryś, J., Kruczak, A., Gruchała, A., Jaszcz-Gruchała, A., Dańda, D., Przewoźnik, M., & Halaszka, K. (2018) · Polish Journal of Pathology · doi:10.5114/pjp.2017.72451 · Cited by 2 · see citing works

Unusual subcutaneous dedifferentiated liposarcoma exhibiting coexistence of meningothelial‐like whorls and inflammatory myofibroblastic tumor‐like structures

Chen, S., He, S., Huang, H., Li, L., Wang, W., Cui, Z., & Zhang, R. (2019) · Journal of Cutaneous Pathology · doi:10.1111/cup.13621 · Cited by 2 · see citing works

Whole exome sequencing of well-differentiated liposarcoma and dedifferentiated liposarcoma in older woman: a case report

Zhao, Z., Chen, X., Xu, J., Shi, Y., Mak, T. K., Huo, M., & Zhang, C. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1237246 · Cited by 1 · see citing works

Deciphering the prognostic and therapeutic significance of BAG1 and BAG2 for predicting distinct survival outcome and effects on liposarcoma

Lian, Y., Chen, J., Han, J., Zhao, B., Wu, J., Li, X., Yue, M., Hou, M., Wu, T., Ye, T., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-67659-6 · Cited by 1 · see citing works

Prognosis of dedifferentiated liposarcoma based on surveillance, epidemiology, and end results database

Zhu, L., Duan, X., & Deng, L. (2025) · European journal of medical research · doi:10.1186/s40001-025-03527-x · Cited by 1 · see citing works

A Case of Atypical Lipomatous Tumor that Dedifferentiated with Second Recurrence after Additional Resection

Hashimoto, K., Nishimura, S., & Akagi, M. (2018) · Cureus · doi:10.7759/cureus.2954 · Cited by 1 · see citing works

Recurrent paratesticular giant liposarcoma: A case report and literature review

Hua, R., Zhao, L., Li, X., Ji, S., Huang, J., & Hua, Q. (2023) · Frontiers in Surgery · doi:10.3389/fsurg.2023.1171952 · Cited by 1 · see citing works

Pattern and Management of Recurrent Retroperitoneal Liposarcoma

Pennacchioli, E., Barberis, M. C. P., & Rizzo, S. (2018) · Updates in surgery/Updates in surgery series · doi:10.1007/978-88-470-3980-3_8

Pleomorphic Sarcomas

Tos, A. P. D. (2018) · Cambridge University Press eBooks · doi:10.1017/9781316535097.009

The Independent Prognostic Nomogram Models for Primary and Recurrent Retroperitoneal Liposarcoma: A Retrospective, Multicentre, Population-Based Cohort StudyPreprint

Deng, H., Lu, Z., Wang, B., Wang, Y., Xiao, L., & Pan, Y. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4962448

A Case of Recurrent Atypical Lipomatous Tumor

Anju, K., Oya, K., Ishii, Y., & Fujisawa, Y. (2024) · American Journal of Dermatopathology · doi:10.1097/dad.0000000000002844

A Novel Odontogenic Carcinoma with CDK4/MDM2 Co-Amplification: Expanding the Phenotypic Spectrum of Malignant Odontogenic Entities

Ren, M., Yang, J., Sun, Y., Yang, S., Wang, L., Cheng, J., Zhang, H., Tu, S., Xu, T., Yang, X., et al. (2025) · Head and Neck Pathology · doi:10.1007/s12105-025-01827-6

Distinct levels of DDIT3 Amplification in Dedifferentiated Liposarcoma Developing After DDIT3 Rearrangement in Myxoid Liposarcoma

Jo, U., Song, M. J., Jeong, J.-S., Song, H., & Song, J. S. (2025) · Applied immunohistochemistry & molecular morphology · doi:10.1097/pai.0000000000001275

The independent prognostic nomogram models for primary and recurrent retroperitoneal liposarcoma: a population-based cohort study

Deng, H., Lu, Z., Wang, Y., Xiao, L., & Pan, Y. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1642820

The contribution of MDM2 gene amplification to the differential diagnosis of liposarcomas: clinical practice in a tertiary health care facility

PAPAKOSTA, A., Machaira, L., Kyriazoglou, A. I., MICHALI, D., Agrogiannis, G. D., Rizou, E., Venetikou, M., Thalassinos, N., & Anthouli-Anagnostopoulou, F. (2025) · Epitheorese Klinikes Farmakologias kai Farmakokinetikes – Greek Edition · doi:10.61873/lywv1613

Next-Generation Sequencing in Malignant Mesenchymal Tumors

Sioletic, S., Bellan, E., & Cin, P. D. (2026) · Current clinical pathology · doi:10.1007/978-3-032-18790-1_7

MDM2 gene amplification in surgical pathology: biology, diagnostic utility, and clinical relevance in the modern era

AL-Zaidi, R. S., Baraban, E. G., & Gross, J. M. (2026) · Seminars in Diagnostic Pathology · doi:10.1016/j.semdp.2026.151029

An immunohistochemical based assessment of murine double minute 2 (MDM2) and cyclin-dependent kinase 4 (CDK4) in jaw osteosarcoma and benign osseous lesions

Jha, S., Urs, A. B., Augustine, J., & Kumar, P. (2026) · Oral and Maxillofacial Surgery · doi:10.1007/s10006-026-01605-w

Tumorigenesis of well-differentiated and dedifferentiated liposarcoma: 12q amplicon architecture, oncogenic cargo, and evolutionary progression

Zhuang, A., Zhou, X., Chengfei, X., Chen, Y., Wang, X., Li, R., Hu, J., Cheng, Y., Wan, Y., Wu, T., et al. (2026) · Cancer and Metastasis Reviews · doi:10.1007/s10555-026-10363-w

Correlating Copy Number Alterations in Dedifferentiated Liposarcoma With Tumor Behavior and Patient Outcome

Liu, Y. (2016) · Cancer Genetics · doi:10.1016/j.cancergen.2016.05.011

High level of CDK4 amplification is a poor prognostic factor in well-differentiated and dedifferentiated liposarcoma.

Lee, S. E., Kim, Y. J., Kwon, M. J., Choi, D. I., Lee, J., Cho, J., Seo, S. W., Kim, S. J., Shin, Y. K., & Choi, Y. (2014) · PubMed · doi:10.14670/hh-29.127 · Cited by 55 · see citing works

Prognostic significance of the MDM2 / HMGA2 ratio and histological tumor grade in dedifferentiated liposarcoma

Yamashita, K., Kohashi, K., Yamada, Y., Akatsuka, S., Ikuta, K., Nishida, Y., Toyokuni, S., & Oda, Y. (2020) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22899 · Cited by 17 · see citing works

Prognostic relevance of Fédération Nationale des Centres de Lutte Contre le Cancer grade and MDM2 amplification levels in dedifferentiated liposarcoma: a study of 50 cases

Jour, G., Gullett, A. E., Liu, M., & Hoch, B. L. (2014) · Modern Pathology · doi:10.1038/modpathol.2014.88 · Cited by 49 · see citing works

Prognostic Implications of MDM2 and CDK4 Co-amplification in Liposarcoma: Insights from FISH analysis for Translational Oncology

James, J., Yajid, A. I., Yahaya, S., Abdullah, S., & Sharif, S. E. T. (2025) · Clinical & Translational Oncology · doi:10.1007/s12094-025-03989-9 · Cited by 9 · see citing works